Close
Nordic 9Nordic 9

Arrowfield Capital (investor - Angel Investor)

United Kingdom
See something wrong or missing? Let us know
Offices:Oxford

Arrowfield Capital is a Oxford-based life sciences angel syndicate focused on building innovative ideas and companies from pre-seed stage

Average round investment:7.49M USD
Average number per year:1.0
Distribution: 2023 (1)
Portfolio companies: United Kingdom PharmEnable
Mostly invests in: United Kingdom United Kingdom (1) Competitive Intelligence (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Arrowfield Capital

Name Criteria
United States MP Healthcare Venture Management
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Competitive Intelligence, Health services, Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Anaxago
88%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Competitive Intelligence, Health services, Pharma
  • Similar business models: B2B, SAAS
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
Germany Rheingau Founders GmbH
88%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Competitive Intelligence, Health services, Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.2
  • Active last 12 months: Yes
United Kingdom Seneca Partners
88%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Competitive Intelligence, Health services, Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.4
France Nicolas Douay
87%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Competitive Intelligence, Health services, Pharma
  • Similar business models: B2B, SAAS
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
Switzerland infinitas capital group
87%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Competitive Intelligence, Health services, Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.3
United Kingdom John Taysom
87%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Competitive Intelligence, Health services, Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.5
Finland Springvest Oy
87%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Competitive Intelligence, Health services, Pharma
  • Similar business models: B2B, SAAS
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
France Octave Klaba
87%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Competitive Intelligence, Health services, Pharma
  • Similar business models: B2B, SAAS
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Lithuania Practica Capital
87%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Competitive Intelligence, Health services, Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.9
Top